Re-evaluating surgical treatment protocol for unstable proximal humerus fractures: emphasizing soft tissue preservation via minimally invasive approach over structural allograft augmentation in deltopectoral approach. A single-center retrospective study.

BACKGROUND

Managing unstable proximal humerus fractures (PHFs), particularly in elderly patients, is challenging due to the need to balance stability with minimizing surgical trauma. The conventional deltopectoral (DP) approach with structural allograft for medial support is widely used but can involve significant soft tissue disruption. This study compares clinical and radiographic outcomes between a minimally invasive deltoid-split (MIS-DS) approach without allograft and the traditional DP approach with allograft.

METHODS

We conducted a single-center, retrospective case-control study of 171 patients with unstable Neer's 3- and 4-part PHFs treated from January 2016 to July 2021. Patients were divided into 2 groups: the MIS-DS approach without graft augmentation (MIS-DS WOG, n = 90) and the DP approach with graft augmentation (DP WG, n = 81). Outcome measures included range of motion, Constant-Murley, American Shoulder and Elbow Surgeons, Quick Disabilities of the Arm, Shoulder, and Hand scores, and radiographic evaluations for fracture union, varus collapse, and screw perforation over a mean follow-up of 29.0 ± 2.4 months.

RESULTS

Clinical outcomes, including Constant-Murley and American Shoulder and Elbow Surgeons scores, range of motion, and Quick Disabilities of the Arm, Shoulder, and Hand, were comparable between the 2 groups. Radiographic assessments showed an avascular necrosis rate of 6.4%, varus collapse of 11.1%, and screw perforation of 8.8% across both cohorts. The DPA with G group demonstrated a shorter mean surgical time, though reoperation rates did not significantly differ.

CONCLUSION

The MIS-DS approach, which emphasizes soft tissue preservation, achieves clinical and radiographic outcomes comparable to those of the DP approach with structural allograft augmentation in treating unstable PHFs. Given the similar outcomes between these techniques, surgeons may choose the approach they are most comfortable with, based on their expertise and the specific needs of the patient. Further prospective studies are recommended to validate these findings across larger populations.